Rex D. Geveden - Nov 12, 2025 Form 4 Insider Report for BWX Technologies, Inc. (BWXT)

Role
President and CEO, Director
Signature
/s/ Rex D. Geveden, by Theresa B. Taylor, attorney-in-fact
Stock symbol
BWXT
Transactions as of
Nov 12, 2025
Transactions value $
-$1,979,005
Form type
4
Date filed
11/13/2025, 05:06 PM
Previous filing
Aug 8, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Geveden Rex D President and CEO, Director 800 MAIN STREET, 4TH FLOOR, LYNCHBURG /s/ Rex D. Geveden, by Theresa B. Taylor, attorney-in-fact 2025-11-13 0001408482

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BWXT Common Stock Sale -$138K -709 -0.36% $195.08 197K Nov 12, 2025 Direct F1, F2
transaction BWXT Common Stock Sale -$386K -1.96K -1% $196.74 195K Nov 12, 2025 Direct F1, F3
transaction BWXT Common Stock Sale -$566K -2.86K -1.47% $197.69 192K Nov 12, 2025 Direct F1, F4
transaction BWXT Common Stock Sale -$480K -2.41K -1.26% $198.67 190K Nov 12, 2025 Direct F1, F5
transaction BWXT Common Stock Sale -$409K -2.05K -1.08% $199.37 188K Nov 12, 2025 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/11/2025.
F2 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $194.7200 to $195.6100 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F3 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $196.0200 to $197.0100 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $197.1350 to $198.1300 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $198.1700 to $199.1250 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $199.1900 to $199.8500 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.